BÂRRX Medical, Inc. is a medical device company, founded to develop solutions for Barrett's esophagus. Millions of Americans suffer from Barrett's esophagus, a pre-cancerous change to the thin layer of tissue lining the esophagus.1 Barrett's esophagus results from chronic gastroesophageal reflux.

BÂRRX Medical has developed an FDA cleared device designed to remove the thin layer of esophageal lining containing Barrett's esophagus cells. The procedure offers a potential alternative to “watchful waiting” for Barrett's esophagus patients currently in surveillance endoscopy programs. The procedure is currently the subject of multi-center clinical trials in the U.S. Early results from these studies have demonstrated that the Barrett's esophageal tissue was completely removed and replaced by normal, healthy tissue in the majority of the procedures performed.